Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents

European Neuropsychopharmacology

Volumn 19, Issue 7, 2009, Pages 487-498

  Fattore, Liana ^a,b   Spano, Maria Sabrina ^b   Cossu, Gregorio ^b   Scherma, Maria ^b   Fratta, Walter ^a,b   Fadda, Paola ^b  

^a CNR   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Drug addiction; GABA B receptor; Nicotine self administration; Place conditioning; Reinstatement; Relapse

Indexed keywords

BACLOFEN; NICOTINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; LOCOMOTION; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REINFORCEMENT;

ANIMALS; BACLOFEN; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; EXTINCTION, PSYCHOLOGICAL; GABA AGONISTS; MALE; MICE; MICE, INBRED C57BL; NICOTINE; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT (PSYCHOLOGY); REINFORCEMENT SCHEDULE; SELF ADMINISTRATION; TOBACCO USE DISORDER;

EID: 67349230312     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2009.01.007     Document Type: Article

References (100)

1. Addolorato G., Caputo F., Capristo E., Colombo G., Gessa G.L., and Gasbarrini G. Ability of baclofen in reducing alcohol craving and intake: II-preliminary clinical evidence. Alcohol Clin. Exp. Res. 24 (2000) 67-71
2. Addolorato G., Caputo F., Capristo E., Domenicali M., Bernardi M., Janiri L., Agabio R., Colombo G., Gessa G.L., and Gasbarrini G. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. Alcohol Alcohol. 37 (2002) 504-508
3. Addolorato G., Leggio L., Abenavoli L., Agabio R., Caputo F., Capristo E., Colombo G., Gessa G.L., and Gasbarrini G. Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam. Am. J. Med. 119 (2006) 276.e13-18
4. Addolorato G., Leggio L., Ferrulli A., Cardone S., Vonghia L., Mirijello A., Abenavoli L., D'Angelo C., Caputo F., Zambon A., Haber P.S., and Gasbarrini G. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet 370 (2007) 1915-1922
5. Ahmadi-Abhari S.A., Akhondzadeh S., Assadi S.M., Shabestari O.L., Farzanehgan Z.M., and Kamlipour A. Baclofen versus clonidine in the treatment of opiates withdrawal, side-effects aspect: a double-blind randomized controlled trial. J. Clin. Pharm. Ther. 26 (2001) 67-71
6. Alkondon M., Pereira E.F., Eisenberg H.M., and Albuquerque E.X. Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices. J. Neurosci. 19 (1999) 2693-2705
7. Anstrom K.K., Cromwell H.C., Markowski T., and Woodward D.J. Effect of baclofen on alcohol and sucrose self-administration in rats. Alcohol. Clin. Exp. Res. 27 (2003) 900-908
8. Assadi S.M., Radgoodarzi R., and Ahmadi-Abhari S.A. Baclofen for maintenance treatment of opioid dependence: a randomized double-blind placebo-controlled clinical trial. BMC Psychiatry 3 (2003) 16-26
9. Azam L., Winzer-Serhan U.H., Chen Y., and Leslie F.M. Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons. J. Comp. Neurol. 444 (2002) 260-274
10. Backes E.N., and Hemby S.E. Contribution of ventral tegmental GABA receptors to cocaine self-administration in rats. Neurochem. Res. 33 (2008) 459-467
11. Bechtholt A.J., and Cunningham C.L. Ethanol-induced conditioned place preference is expressed through a ventral tegmental area dependent mechanism. Behav. Neurosci. 119 (2005) 213-223
12. Besheer J., Lepoutre V., and Hodge C.W. GABA(B) receptor agonists reduce operant ethanol self-administration and enhance ethanol sedation in C57BL/6J mice. Psychopharmacology 174 (2004) 358-366
13. Bienkowski P., Rogowski A., Korkosz A., Mierzejewski P., Radwanska K., Kaczmarek L., Bogucka-Bonikowska A., and Kostowski W. Time-dependent changes in alcohol-seeking behaviour during abstinence. Eur. Neuropsychopharmacol. 14 (2004) 355-360
14. Bowery N. GABAB receptors and their significance in mammalian pharmacology. Trends Pharmacol. Sci. 10 (1989) 401-407
15. Bowery N.G., Hudson A.L., and Price G.W. GABAA and GABAB receptor site distribution in the rat central nervous system. Neuroscience 20 (1987) 365-383
16. Brebner K., Froestl W., Andrews M., Phelan R., and Roberts D.C. The GABA(B) agonist CGP 44532 decreases cocaine self-administration in rats: demonstration using a progressive ratio and a discrete trials procedure. Neuropharmacology 38 (1999) 1797-1804
17. Brebner K., Phelan R., and Roberts D.C. Intra-VTA baclofen attenuates cocaine self-administration on a progressive ratio schedule of reinforcement. Pharmacol. Biochem. Behav. 66 (2000) 857-862
18. Brebner K., Ahn S., and Phillips A.G. Attenuation of d-amphetamine self-administration by baclofen in the rat: behavioral and neurochemical correlates. Psychopharmacology 177 (2005) 409-417
19. Campbell U.C., Lac S.T., and Carroll M.E. Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats. Psychopharmacology 143 (1999) 209-214
20. Chiamulera C., Borgo C., Falchetto S., Valerio E., and Tessari M. Nicotine reinstatement of nicotine self-administration after long-term extinction. Psychopharmacology 127 (1996) 102-107
21. Clements J.R., and Grant S. Glutamate-like immunoreactivity in neurons of the laterodorsal tegmental and pedunculopontine nuclei in the rat. Neurosci. Lett. 120 (1990) 70-73
22. Colombo G., Agabio R., Carai M.A., Lobina C., Pani M., Reali R., Addolorato G., and Gessa G.L. Ability of baclofen in reducing alcohol intake and withdrawal severity: I-preclinical evidence. Alcohol. Clin. Exp. Res. 24 (2000) 58-66
23. Colombo G., Serra S., Brunetti G., Vacca G., Carai M.A., and Gessa G.L. Suppression by baclofen of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats. Drug Alcohol Depend. 70 (2003) 105-108
24. Colombo G., Vacca G., Serra S., Brunetti G., Carai M.A., and Gessa G.L. Baclofen suppresses motivation to consume alcohol in rats. Psychopharmacology 167 (2003) 221-224
25. Corrigall W.A., Coen K.M., Adamson K.L., Chow B.L., and Zhang J. Response of nicotine self-administration in the rat to manipulations of mu-opioid and gamma-aminobutyric acid receptors in the ventral tegmental area. Psychopharmacology 149 (2000) 107-114
26. Corrigall W.A., Coen K.M., Zhang J., and Adamson K.L. GABA mechanisms in the pedunculopontine tegmental nucleus influence particular aspects of nicotine self-administration selectively in the rat. Psychopharmacology 158 (2001) 190-197
27. Cousins M.S., Stamat H.M., and de Wit H. Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking. Nicotine Tob. Res. 3 (2001) 123-129
28. Cousins M.S., Roberts D.C., and de Wit H. GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings. Drug Alcohol Depend. 65 (2002) 209-220
29. De Vries T.J., Schoffelmeer A.N., Binnekade R., Mulder A.H., and Vanderschuren L.J. Drug-induced reinstatement of heroin- and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioural sensitization. Eur. J. Neurosci. 10 (1998) 3565-3571
30. Di Ciano P., and Everitt B.J. The GABA(B) receptor agonist baclofen attenuates cocaine- and heroin-seeking behavior by rats. Neuropsychopharmacology 28 (2003) 510-518
31. Diergaarde L., de Vries W., Raasø H., Schoffelmeer A.N., and De Vries T.J. Contextual renewal of nicotine seeking in rats and its suppression by the cannabinoid-1 receptor antagonist Rimonabant (SR141716A). Neuropharmacology 55 (2008) 712-716
32. Dobrovitsky V., Pimentel P., Duarte A., Froestl W., Stellar J.R., and Trzcińska M. CGP 44532, a GABAB receptor agonist, is hedonically neutral and reduces cocaine-induced enhancement of reward. Neuropharmacology 42 (2002) 626-632
33. Erhardt S., Mathé J.M., Chergui K., Engberg G., and Svensson T.H. GABA(B) receptor-mediated modulation of the firing pattern of ventral tegmental area dopamine neurons in vivo. Naunyn Schmiedebergs Arch. Pharmacol. 365 (2002) 173-180
34. Exley R., Clements M.A., Hartung H., McIntosh J.M., and Cragg S.J. Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens. Neuropsychopharmacology 33 (2008) 2158-2166
35. Fadda P., Scherma M., Fresu A., Collu M., and Fratta W. Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat. Synapse 50 (2003) 1-6
36. Fattore L., Cossu G., Martellotta M.C., and Fratta W. Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats. Psychopharmacology 156 (2001) 410-416
37. Fattore L., Cossu G., Martellotta M.C., Deiana S., and Fratta W. Baclofen antagonises intravenous self-administration of gamma-hydroxybutyric acid in mice. NeuroReport 12 (2001) 2243-2246
38. Fattore L., Cossu G., Martellotta M.C., and Fratta W. Baclofen antagonizes intravenous self-administration of nicotine in mice and rats. Alcohol Alcohol. 37 (2002) 495-498
39. Fattore L., Spano M.S., Cossu G., Deiana S., and Fratta W. Cannabinoid mechanism in reinstatement of heroin-seeking after a long period of abstinence in rats. Eur. J. Neurosci. 17 (2003) 1723-1726
40. Fattore L., Spano S., Cossu G., Deiana S., Fadda P., and Fratta W. Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats. Neuropharmacology 48 (2005) 1097-1104
41. Fattore L., Piras G., Corda M.G., and Giorgi O. The Roman high- and low-avoidance rat lines differ in the acquisition, maintenance, extinction, and reinstatement of intravenous cocaine self-administration. Neuropsychopharmacology. (2008) doi:10.1038/npp.2008.43
42. Filip M., and Frankowska M. Effects of GABA(B) receptor agents on cocaine priming, discrete contextual cue and food induced relapses. Eur. J. Pharmacol. 571 (2007) 166-173
43. Ford B., Holmes C.J., Mainville L., and Jones B.E. GABAergic neurons in the rat pedunculopontine tegmentum: codistribution with cholinergic and other tegmental neurons projecting to the posterior lateral hypothalamus. J. Comp. Neurol. 363 (1995) 177-196
44. Franklin, T.R., Harper, D., Kampman, K., Kildea, S., Jens, W., Lynch, K., O'Brien, C.P., Childress, A.R., in press. The GAGA-B agonist baclofen suppresses cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study. Drug and Alcohol Depend.
45. Frishman W.H. Smoking cessation pharmacotherapy-nicotine and non-nicotine preparations. Prev. Cardiol. 10 (2007) 10-22
46. Gaimarri A., Moretti M., Riganti L., Zanardi A., Clementi F., and Gotti C. Regulation of neuronal nicotinic receptor traffic and expression. Brain Res. Rev. 55 (2007) 134-143
47. Grabus S.D., Martin B.R., Brown S.E., and Damaj M.I. Nicotine place preference in the mouse: influences of prior handling, dose and strain and attenuation by nicotinic receptor antagonists. Psychopharmacology 184 (2006) 456-463
48. Jones I.W., and Wonnacott S. Precise localization of alpha7 nicotinic acetylcholine receptors on glutamatergic axon terminals in the rat ventral tegmental area. J. Neurosci. 24 (2004) 11244-11252
49. Kaplan G.B., Leite-Morris K.A., Joshi M., Shoeb M.H., and Carey R.J. Baclofen inhibits opiate-induced conditioned place preference and associated induction of Fos in cortical and limbic regions. Brain Res. 987 (2003) 122-125
50. Kosaka T.M., Tauchi M., and Dahl J.L. Cholinergic neurons containing GABA-like and/or glutamic acid decarboxylase-like immunoreactivities in various brain regions of the rat. Exp. Brain Res. 70 (1988) 605-617
51. Lança A.J., Sanelli T.R., and Corrigall W.A. Nicotine-induced fos expression in the pedunculopontine mesencephalic tegmentum in the rat. Neuropharmacology 39 (2000) 2808-2817
52. Lancaster T., Stead L., and Cahill K. An update on therapeutics for tobacco dependence. Expert Opin. Pharmacother. 9 (2008) 15-22
53. Le Foll B., and Goldberg S.R. Nicotine induces conditioned place preferences over a large range of doses in rats. Psychopharmacology 178 (2005) 481-492
54. Le Foll B., Wertheim C.E., and Goldberg S.R. Effects of baclofen on conditioned rewarding and discriminative stimulus effects of nicotine in rats. Neurosci. Lett. 443 (2008) 236-240
55. Leite-Morris K.A., Fukudome E.Y., Shoeb M.H., and Kaplan G.B. GABA(B) receptor activation in the ventral tegmental area inhibits the acquisition and expression of opiate-induced motor sensitization. J. Pharmacol. Exp. Ther. 308 (2004) 667-678
56. Li S.M., Yin L.L., Ren Y.H., Pan L.S., and Zheng J.W. GABA(B) receptor agonist baclofen attenuates the development and expression of d-methamphetamine-induced place preference in rats. Life Sci. 70 (2001) 349-356
57. Lile J.A., Stoops W.W., Allen T.S., Glaser P.E., Hays L.R., and Rush C.R. Baclofen does not alter the reinforcing, subject-rated or cardiovascular effects of intranasal cocaine in humans. Psychopharmacology 171 (2004) 441-449
58. Lindblom N., de Villiers S.H., Kalayanov G., Gordon S., Johansson A.M., and Svensson T.H. Active immunization against nicotine prevents reinstatement of nicotine-seeking behavior in rats. Respiration 69 (2002) 254-260
59. Ling W., Shoptaw S., and Majewska D. Baclofen as a cocaine anti-craving medication: a preliminary clinical study. Neuropsychopharmacology 18 (1998) 403-404
60. Lu L., Dempsey J., Liu S.Y., Bossert J.M., and Shaham Y. A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal. J. Neurosci. 24 (2004) 1604-1611
61. Maccioni P., Serra S., Vacca G., Orrù A., Pes D., Agabio R., Addolorato G., Carai M.A., Gessa G.L., and Colombo G. Baclofen-induced reduction of alcohol reinforcement in alcohol-preferring rats. Alcoholism 36 (2005) 161-168
62. Maccioni P., Bienkowski P., Carai M.A., Gessa G.L., and Colombo G. Baclofen attenuates cue-induced reinstatement of alcohol-seeking behavior in Sardinian alcohol-preferring (sP) rats. Drug Alcohol Depend. 95 (2008) 284-287
63. Mansvelder H.D., Keath J.R., and McGehee D.S. Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 33 (2002) 905-919
64. Mombereau C., Lhuillier L., Kaupmann K., and Cryan J.F. GABAB receptor-positive modulation-induced blockade of the rewarding properties of nicotine is associated with a reduction in nucleus accumbens DeltaFosB accumulation. J. Pharmacol. Exp. Ther. 321 (2007) 172-177
65. Nashmi R., and Lester H.A. CNS localization of neuronal nicotinic receptors. J. Mol. Neurosci. 30 (2006) 181-184
66. Nides M. Update on pharmacologic options for smoking cessation treatment. Am. J. Med. 121 4 Suppl (2008) S20-31
67. Ong J., and Kerr D.I. Clinical potential of GABAB receptor modulators. CNS Drug Rev. 11 (2005) 317-334
68. Palmatier M.I., and Bevins R.A. Examination of GABAergic and dopaminergic compounds in the acquisition of nicotine-conditioned hyperactivity in rats. Neuropsychobiology 45 (2002) 87-94
69. Panagis G., and Kastellakis A. The effects of ventral tegmental administration of GABA(A), GABA(B), NMDA and AMPA receptor agonists on ventral pallidum self-stimulation. Behav. Brain Res. 131 (2002) 115-123
70. Paredes R., and Agmo A. Stereospecific actions of baclofen on socio-sexual behavior, locomotor activity and motor execution. Psychopharmacology 97 (1989) 358-364
71. Paterson D., and Nordberg A. Neuronal nicotinic receptors in the human brain. Prog. Neurobiol. 61 (2000) 75-111
72. Paterson N.E., Froestl W., and Markou A. The GABAB receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat. Psychopharmacology 172 (2004) 179-186
73. Paterson N.E., Froestl W., and Markou A. Repeated administration of the GABAB receptor agonist CGP44532 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine-seeking in rats. Neuropsychopharmacology 30 (2005) 119-128
74. Pons S., Fattore L., Cossu G., Tolu S., Porcu E., McIntosh J.M., Changeux J.P., Maskos U., and Fratta W. Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration. J. Neurosci. 28 (2008) 12318-12327
75. Quik M., Polonskaya Y., Gillespie A., Jakowec M., Lloyd G.K., and Langston J.W. Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization. J. Comp. Neurol. 425 (2000) 58-69
76. Ranaldi R., and Poeggel K. Baclofen decreases methamphetamine self-administration in rats. NeuroReport 13 (2002) 1107-1110
77. Roberts D.C., and Andrews M.M. Baclofen suppression of cocaine self-administration: demonstration using a discrete trials procedure. Psychopharmacology 131 (1997) 271-277
78. Roberts D.C., Andrews M.M., and Vickers G.J. Baclofen attenuates the reinforcing effects of cocaine in rats. Neuropsychopharmacology 15 (1996) 417-423
79. Rogers J.L., and See R.E. Selective inactivation of the ventral hippocampus attenuates cue-induced and cocaine-primed reinstatement of drug-seeking in rats. Neurobiol. Learn. Mem. 87 (2007) 688-692
80. Sahraei H., Amiri Y.A., Haeri-Rohani A., Sepehri H., Salimi S.H., Pourmotabbed A., Ghoshooni H., Zahirodin A., and Zardooz H. Different effects of GABAergic receptors located in the ventral tegmental area on the expression of morphine-induced conditioned place preference in rat. Eur. J. Pharmacol. 524 (2005) 95-101
81. Scherma M., Panlilio L.V., Fadda P., Fattore L., Gamaleddin I., Le Foll B., Justinova Z., Mikics E., Haller J., Medalie J., Stroik J., Barnes C., Yasar S., Tanda G., Piomelli D., Fratta W., and Goldberg S.R. Inhibition of anandamide hydrolysis by URB597 reverses abuse-related behavioral and neurochemical effects of nicotine in rats. J. Pharmacol. Exp. Ther. 327 (2008) 482-490
82. Schmidt E.D., Voorn P., Binnekade R., Schoffelmeer A.N., and De Vries T.J. Differential involvement of the prelimbic cortex and striatum in conditioned heroin and sucrose seeking following long-term extinction. Eur. J. Neurosci. 22 (2005) 2347-2356
83. Shoaib M., Swanner L.S., Beyer C.E., Goldberg S.R., and Schindler C.W. The GABAB agonist baclofen modifies cocaine self-administration in rats. Behav. Pharmacol. 9 (1998) 195-206
84. Shoptaw S., Yang X., Rotheram-Fuller E.J., Hsieh Y.C., Kintaudi P.C., Charuvastra V.C., and Ling W. Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use. J. Clin. Psychiatry 64 (2003) 1440-1448
85. Slattery D.A., Markou A., Froestl W., and Cryan J.F. The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat. Neuropsychopharmacology 30 (2005) 2065-2072
86. Solecki W., Krówka T., Filip M., and Przewłocki R. Role of opioidergic mechanisms and GABA uptake inhibition in the heroin-induced discriminative stimulus effects in rats. Pharmacol. Rep. 57 (2005) 744-754
87. Spano M.S., Fattore L., Cossu G., Deiana S., Fadda P., and Fratta W. CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat. Br. J. Pharmacol. 143 (2004) 343-350
88. Spano M.S., Fattore L., Fratta W., and Fadda P. The GABAB receptor agonist baclofen prevents heroin-induced reinstatement of heroin-seeking behavior in rats. Neuropharmacology 52 (2007) 1555-1562
89. Suzuki T., Nurrochmad A., Ozaki M., Khotib J., Nakamura A., Imai S., Shibasaki M., Yajima Y., and Narita M. Effect of a selective GABA(B) receptor agonist baclofen on the mu-opioid receptor agonist-induced antinociceptive, emetic and rewarding effects. Neuropharmacology 49 (2005) 1121-1131
90. Tzschentke T.M. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict. Biol. 12 (2007) 227-462
91. Vacher C.M., and Bettler B. GABA(B) receptors as potential therapeutic targets. Curr. Drug Targets CNS Neurol. Disord. 2 (2003) 248-259
92. Walker B.M., and Koob G.F. The gamma-aminobutyric acid-B receptor agonist baclofen attenuates responding for ethanol in ethanol-dependent rats. Alcohol. Clin. Exp. Res. 31 (2007) 11-18
93. Waraczynski M. GABA receptor agonism in the sublenticular central extended amygdala impairs medial forebrain bundle self-stimulation but GABA blockade does not enhance it. Behav. Brain Res. 187 (2008) 396-404
94. Weerts E.M., Froestl W., Kaminski B.J., and Griffiths R.R. Attenuation of cocaine-seeking by GABA B receptor agonists baclofen and CGP44532 but not the GABA reuptake inhibitor tiagabine in baboons. Drug Alcohol Depend. 89 (2007) 206-213
95. Westerink B.H., Kwint H.F., and De Vries J.B. The pharmacology of mesolimbic dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and nucleus accumbens of the rat brain. J. Neurosci. 16 (1996) 2605-2611
96. Willick M.L., and Kokkinidis L. The effects of ventral tegmental administration of GABAA, GABAB and NMDA receptor agonists on medial forebrain bundle self-stimulation. Behav. Brain Res. 70 (1995) 31-36
97. Wirtshafter D., and Sheppard A.C. Localization of GABA(B) receptors in midbrain monoamine containing neurons in the rat. Brain Res. Bull. 56 (2001) 1-5
98. Xi Z.X., and Stein E.A. Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release. J. Pharmacol. Exp. Ther. 290 (1999) 1369-1374
99. Yun I.A., Wakabayashi K.T., Fields H.L., and Nicola S.M. The ventral tegmental area is required for the behavioral and nucleus accumbens neuronal firing responses to incentive cues. J. Neurosci. 24 (2004) 2923-2933
100. Zarrindast M.R., Massoudi R., Sepehri H., and Rezayof A. Involvement of GABA(B) receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats. Physiol. Behav. 87 (2006) 31-38